{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:27:10Z","timestamp":1787502430315,"version":"build-2736575974"},"reference-count":25,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"\n OBJECTIVE<\/jats:title>\n The purpose of this study was to identify rates of and risk factors for local tumor progression in patients who had undergone surgery or radiosurgery for the management of cerebellar hemangioblastoma and to describe treatments pursued following tumor progression.<\/jats:p>\n <\/jats:sec>\n \n METHODS<\/jats:title>\n The authors conducted a retrospective single-center review of patients who had undergone treatment of a cerebellar hemangioblastoma with either surgery or stereotactic radiosurgery (SRS) between 1996 and 2019. Univariate and multivariate regression analyses were performed to examine factors associated with local tumor control.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n \n One hundred nine patients met the study inclusion criteria. Overall, these patients had a total of 577 hemangioblastomas, 229 of which were located in the cerebellum. The surgical and SRS cohorts consisted of 106 and 123 cerebellar hemangioblastomas, respectively. For patients undergoing surgery, tumors were treated with subtotal resection and gross-total resection in 5.7% and 94.3% of cases, respectively. For patients receiving SRS, the mean target volume was 0.71 cm\n 3<\/jats:sup>\n and the mean margin dose was 18.0 Gy. Five-year freedom from lesion progression for the surgical and SRS groups was 99% and 82%, respectively. The surgical and SRS cohorts contained 32% versus 97% von Hippel\u2013Lindau tumors, 78% versus 7% cystic hemangioblastomas, and 12.8- versus 0.56-cm\n 3<\/jats:sup>\n mean tumor volumes, respectively. On multivariate analysis, factors associated with local tumor progression in the SRS group included older patient age (HR 1.06, 95% CI 1.03\u20131.09, p < 0.001) and a cystic component (HR 9.0, 95% CI 2.03\u201332.0, p = 0.001). Repeat SRS as salvage therapy was used more often for smaller tumor recurrences, and no tumor recurrences of < 1.0 cm\n 3<\/jats:sup>\n required additional salvage surgery following repeat SRS.\n <\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS<\/jats:title>\n Both surgery and SRS achieve high rates of local control of hemangioblastomas. Age and cystic features are associated with local progression after SRS treatment for cerebellar hemangioblastomas. In cases of local tumor recurrence, salvage surgery and repeat SRS are valid forms of treatment to achieve local tumor control, although resection may be preferable for larger recurrences.<\/jats:p>\n <\/jats:sec>","DOI":"10.3171\/2023.6.jns222629","type":"journal-article","created":{"date-parts":[[2023,8,5]],"date-time":"2023-08-05T11:28:20Z","timestamp":1691234900000},"page":"404-411","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of upfront resection or stereotactic radiosurgery for local control of solid and cystic cerebellar hemangioblastomas"],"prefix":"10.3171","volume":"140","author":[{"given":"Luis R.","family":"Carrete","sequence":"first","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin A.","family":"Morshed","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob S.","family":"Young","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauro N.","family":"Avalos","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny K.","family":"Sneed","sequence":"additional","affiliation":[{"name":"Radiation Oncology, University of California, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish K.","family":"Aghi","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"McDermott","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip V.","family":"Theodosopoulos","sequence":"additional","affiliation":[{"name":"Departments of Neurological Surgery and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"6","key":"b1","series-title":"J Neurosurg","first-page":"1511","article-title":"Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement","volume":"136","author":"Huntoon K","year":"2022","unstructured":"Huntoon K, Shepard MJ, Lukas RV, McCutcheon IE, Daniels AB, Asthagiri AR. Hemangioblastoma diagnosis and surveillance in von Hippel-Lindau disease: a consensus statement. J Neurosurg. 2022;136(6):1511\u20131516."},{"issue":"5","key":"b2","series-title":"J Neurosurg","first-page":"1055","article-title":"Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease","volume":"120","author":"Lonser RR","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K, Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120(5):1055\u20131062."},{"issue":"2","key":"b3","series-title":"J Neurosurg","first-page":"248","article-title":"Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment","volume":"105","author":"Ammerman JM","year":"2006","unstructured":"Ammerman JM, Lonser RR, Dambrosia J, Butman JA, Oldfield EH. Long-term natural history of hemangioblastomas in patients with von Hippel-Lindau disease: implications for treatment. J Neurosurg. 2006;105(2):248\u2013255."},{"issue":"5","key":"b4","series-title":"J Med Genet","first-page":"311","article-title":"Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma","volume":"27","author":"Maher ER","year":"1990","unstructured":"Maher ER, Yates JR, Ferguson-Smith MA. Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J Med Genet. 1990;27(5):311\u2013314."},{"issue":"5","key":"b5","series-title":"Int J Exp Pathol","first-page":"311","article-title":"Central nervous system capillary haemangioblastoma: the pathologist\u2019s viewpoint","volume":"88","author":"Hussein MR","year":"2007","unstructured":"Hussein MR. Central nervous system capillary haemangioblastoma: the pathologist\u2019s viewpoint. Int J Exp Pathol. 2007;88(5):311\u2013324."},{"issue":"3","key":"b6","series-title":"Brain Tumor Pathol","first-page":"111","article-title":"Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas","volume":"17","author":"Miyagami M","year":"2000","unstructured":"Miyagami M, Katayama Y, Nakamura S. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas. Brain Tumor Pathol. 2000;17(3):111\u2013120."},{"issue":"2","key":"b7","series-title":"J Med Genet","first-page":"120","article-title":"A genetic register for von Hippel-Lindau disease","volume":"33","author":"Maddock IR","year":"1996","unstructured":"Maddock IR, Moran A, Maher ER, A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33(2):120\u2013127."},{"issue":"1","key":"b8","series-title":"Neuro Oncol","first-page":"80","article-title":"Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease","volume":"12","author":"Asthagiri AR","year":"2010","unstructured":"Asthagiri AR, Mehta GU, Zach L, Prospective evaluation of radiosurgery for hemangioblastomas in von Hippel-Lindau disease. Neuro Oncol. 2010;12(1):80\u201386."},{"issue":"3","key":"b9","series-title":"Neurosurgery","first-page":"443","article-title":"The role of stereotactic radiosurgery for intracranial hemangioblastomas","volume":"63","author":"Kano H","year":"2008","unstructured":"Kano H, Niranjan A, Mongia S, Kondziolka D, Flickinger JC, Lunsford LD. The role of stereotactic radiosurgery for intracranial hemangioblastomas. Neurosurgery. 2008;63(3):443\u2013451."},{"issue":"3","key":"b10","series-title":"Int J Radiat Oncol Biol Phys","first-page":"493","article-title":"Radiosurgery for hemangioblastoma: results of a multiinstitutional experience","volume":"35","author":"Patrice SJ","year":"1996","unstructured":"Patrice SJ, Sneed PK, Flickinger JC, Radiosurgery for hemangioblastoma: results of a multiinstitutional experience. Int J Radiat Oncol Biol Phys. 1996;35(3):493\u2013499."},{"issue":"suppl","key":"b11","series-title":"J Neurosurg","first-page":"225","article-title":"The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain","volume":"102","author":"Wang EM","year":"2005","unstructured":"Wang EM, Pan L, Wang BJ, The long-term results of gamma knife radiosurgery for hemangioblastomas of the brain. J Neurosurg. 2005;102(suppl):225-229."},{"issue":"2","key":"b12","series-title":"J Neurosurg","first-page":"210","article-title":"Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease","volume":"108","author":"Jagannathan J","year":"2008","unstructured":"Jagannathan J, Lonser RR, Smith R, DeVroom HL, Oldfield EH. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2008;108(2):210\u2013222."},{"issue":"6","key":"b13","series-title":"J Neurosurg","first-page":"1469","article-title":"Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study","volume":"122","author":"Kano H","year":"2015","unstructured":"Kano H, Shuto T, Iwai Y, Stereotactic radiosurgery for intracranial hemangioblastomas: a retrospective international outcome study. J Neurosurg. 2015;122(6):1469\u20131478."},{"issue":"10","key":"b14","series-title":"Acta Neurochir (Wien)","first-page":"1007","article-title":"Gamma knife radiosurgery for intracranial haemangioblastomas","volume":"149","author":"Matsunaga S","year":"2007","unstructured":"Matsunaga S, Shuto T, Inomori S, Fujino H, Yamamoto I. Gamma knife radiosurgery for intracranial haemangioblastomas. Acta Neurochir (Wien). 2007;149(10):1007\u20131013."},{"key":"b15","series-title":"Front Oncol","first-page":"1037","article-title":"Hemangioblastoma instead of renal cell carcinoma plays a major role in the unfavorable overall survival of von Hippel-Lindau disease patients","volume":"9","author":"Zhou B","year":"2019","unstructured":"Zhou B, Wang J, Liu S, Hemangioblastoma instead of renal cell carcinoma plays a major role in the unfavorable overall survival of von Hippel-Lindau disease patients. Front Oncol. 2019;9:1037."},{"issue":"1","key":"b16","series-title":"Neurosurgery","first-page":"79","article-title":"Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas","volume":"65","author":"Moss JM","year":"2009","unstructured":"Moss JM, Choi CYH, Adler JR Jr, Soltys SG, Gibbs IC, Chang SD. Stereotactic radiosurgical treatment of cranial and spinal hemangioblastomas. Neurosurgery. 2009;65(1):79\u201385."},{"issue":"2","key":"b17","series-title":"J Clin Neurosci","first-page":"171","article-title":"Neurosurgical considerations in von Hippel-Lindau disease","volume":"18","author":"Beitner MM","year":"2011","unstructured":"Beitner MM, Winship I, Drummond KJ. Neurosurgical considerations in von Hippel-Lindau disease. J Clin Neurosci. 2011;18(2):171\u2013180."},{"key":"b18","series-title":"Surg Neurol Int","first-page":"138","article-title":"Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review","volume":"5","author":"Br\u00fcndl E","year":"2014","unstructured":"Br\u00fcndl E, Sch\u00f6del P, Ullrich OW, Brawanski A, Schebesch KM. Surgical resection of sporadic and hereditary hemangioblastoma: our 10-year experience and a literature review. Surg Neurol Int. 2014;5:138."},{"issue":"1","key":"b19","series-title":"Neurosurgery","first-page":"55","article-title":"Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease","volume":"48","author":"Conway JE","year":"2001","unstructured":"Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001;48(1):55\u201363."},{"issue":"1","key":"b20","series-title":"Sci Rep","first-page":"11144","article-title":"Assessment of care pattern and outcome in hemangioblastoma","volume":"8","author":"Huang Y","year":"2018","unstructured":"Huang Y, Chan L, Bai HX, Assessment of care pattern and outcome in hemangioblastoma. Sci Rep. 2018;8(1):11144."},{"issue":"5","key":"b21","series-title":"Int J Radiat Oncol Biol Phys","first-page":"1165","article-title":"Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system","volume":"18","author":"Smalley SR","year":"1990","unstructured":"Smalley SR, Schomberg PJ, Earle JD, Laws ER Jr, Scheithauer BW, O\u2019Fallon JR. Radiotherapeutic considerations in the treatment of hemangioblastomas of the central nervous system. Int J Radiat Oncol Biol Phys. 1990;18(5):1165\u20131171."},{"issue":"1","key":"b22","series-title":"Crit Rev Oncol Hematol","first-page":"69","article-title":"Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system","volume":"86","author":"Capitanio JF","year":"2013","unstructured":"Capitanio JF, Mazza E, Motta M, Mortini P, Reni M. Mechanisms, indications and results of salvage systemic therapy for sporadic and von Hippel-Lindau related hemangioblastomas of the central nervous system. Crit Rev Oncol Hematol. 2013;86(1):69\u201384."},{"issue":"2","key":"b23","series-title":"Int J Radiat Oncol Biol Phys","first-page":"499","article-title":"Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy","volume":"65","author":"Ruben JD","year":"2006","unstructured":"Ruben JD, Dally M, Bailey M, Smith R, McLean CA, Fedele P. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006;65(2):499\u2013508."},{"issue":"4","key":"b24","series-title":"J Clin Neurosci","first-page":"485","article-title":"Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations","volume":"20","author":"Rahmathulla G","year":"2013","unstructured":"Rahmathulla G, Marko NF, Weil RJ. Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations. J Clin Neurosci. 2013;20(4):485\u2013502."},{"issue":"3","key":"b25","series-title":"J Magn Reson Imaging","first-page":"571","article-title":"Pseudoprogression of brain tumors","volume":"48","author":"Thust SC","year":"2018","unstructured":"Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imaging. 2018;48(3):571\u2013589."}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/140\/2\/article-p404.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/140\/2\/article-p404.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/140\/2\/article-p404.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T06:21:39Z","timestamp":1716618099000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/140\/2\/article-p404.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":25,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3171\/2023.6.jns222629","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}